243 related articles for article (PubMed ID: 34485029)
1. Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors.
Gao S; Huang T; Song L; Xu S; Cheng Y; Cherukupalli S; Kang D; Zhao T; Sun L; Zhang J; Zhan P; Liu X
Acta Pharm Sin B; 2022 Feb; 12(2):581-599. PubMed ID: 34485029
[TBL] [Abstract][Full Text] [Related]
2. The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Pillaiyar T; Wendt LL; Manickam M; Easwaran M
Med Res Rev; 2021 Jan; 41(1):72-135. PubMed ID: 32852058
[TBL] [Abstract][Full Text] [Related]
3. Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology.
Zhuo LS; Wang MS; Yang JF; Xu HC; Huang W; Shang LQ; Yang GF
Top Curr Chem (Cham); 2021 Apr; 379(3):23. PubMed ID: 33886017
[TBL] [Abstract][Full Text] [Related]
4. Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors.
Paul A; Sarkar A; Saha S; Maji A; Janah P; Kumar Maity T
Bioorg Med Chem; 2021 Sep; 46():116301. PubMed ID: 34332853
[TBL] [Abstract][Full Text] [Related]
5. In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins.
Elmaaty AA; Darwish KM; Khattab M; Elhady SS; Salah M; Hamed MIA; Al-Karmalawy AA; Saleh MM
J Biomol Struct Dyn; 2022; 40(19):8866-8893. PubMed ID: 33928870
[TBL] [Abstract][Full Text] [Related]
6. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
Dhankhar P; Dalal V; Kumar V
J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746
[TBL] [Abstract][Full Text] [Related]
7. Use of hyphenated analytical techniques to identify the bioactive constituents of Gunnera perpensa L., a South African medicinal plant, which potently inhibit SARS-CoV-2 spike glycoprotein-host ACE2 binding.
Invernizzi L; Moyo P; Cassel J; Isaacs FJ; Salvino JM; Montaner LJ; Tietjen I; Maharaj V
Anal Bioanal Chem; 2022 May; 414(13):3971-3985. PubMed ID: 35419694
[TBL] [Abstract][Full Text] [Related]
8. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
Idrees M; Khan S; Memon NH; Zhang Z
Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
[TBL] [Abstract][Full Text] [Related]
9. Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation.
Mondal P; Natesh J; Abdul Salam AA; Thiyagarajan S; Meeran SM
J Biomol Struct Dyn; 2022 Apr; 40(6):2715-2732. PubMed ID: 33150860
[TBL] [Abstract][Full Text] [Related]
10. The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies.
Payandeh Z; Mohammadkhani N; Nabi Afjadi M; Khalili S; Rajabibazl M; Houjaghani Z; Dadkhah M
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):899-910. PubMed ID: 33307883
[No Abstract] [Full Text] [Related]
11. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
12. Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.
Singh M; Trivedi D; Mohapatra R; Bagchi T; Durthi CP; Kuppam C
Curr Pharm Des; 2021 Oct; 27(31):3389-3398. PubMed ID: 34225610
[TBL] [Abstract][Full Text] [Related]
13. Metal Complexes as Antiviral Agents for SARS-CoV-2.
Karges J; Cohen SM
Chembiochem; 2021 Aug; 22(16):2600-2607. PubMed ID: 34002456
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease.
Upadhyay S; Tripathi PK; Singh M; Raghavendhar S; Bhardwaj M; Patel AK
Phytother Res; 2020 Dec; 34(12):3411-3419. PubMed ID: 32748969
[TBL] [Abstract][Full Text] [Related]
15. The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS-CoV-2 targets.
Parida PK; Paul D; Chakravorty D
Phytother Res; 2020 Dec; 34(12):3420-3433. PubMed ID: 32969524
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection.
Maurya VK; Kumar S; Bhatt MLB; Saxena SK
J Biomol Struct Dyn; 2022 Mar; 40(4):1719-1735. PubMed ID: 33073699
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
18. Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors.
Huff S; Kummetha IR; Tiwari SK; Huante MB; Clark AE; Wang S; Bray W; Smith D; Carlin AF; Endsley M; Rana TM
J Med Chem; 2022 Feb; 65(4):2866-2879. PubMed ID: 34570513
[TBL] [Abstract][Full Text] [Related]
19. Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease.
Rabie AM
ACS Omega; 2022 Jun; 7(25):21385-21396. PubMed ID: 35785294
[TBL] [Abstract][Full Text] [Related]
20. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2.
Biering SB; Van Dis E; Wehri E; Yamashiro LH; Nguyenla X; Dugast-Darzacq C; Graham TGW; Stroumza JR; Golovkine GR; Roberts AW; Fines DM; Spradlin JN; Ward CC; Bajaj T; Dovala D; Schulze-Gamen U; Bajaj R; Fox DM; Ott M; Murthy N; Nomura DK; Schaletzky J; Stanley SA
ACS Infect Dis; 2021 Aug; 7(8):2337-2351. PubMed ID: 34129317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]